Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease

Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease

Background/purpose: In 2020, metabolic Associated Fatty Liver Disease (MAFLD) was proposed to replace non-alcoholic fatty liver disease (NAFLD) with new diagnostic criteria. The prevalence and clinical outcomes of MAFLD subtypes remained unclear. Methods: The participants from Taiwan bio-bank cohort...

Full description

Bibliographic Details
Main Authors: Kun-Lin Cheng, Shao-Wen Wang, Yu-Ming Cheng, Tsung-Han Hsieh, Chia-Chi Wang, Jia-Horng Kao
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Journal of the Formosan Medical Association
Subjects:
Atherosclerosis
Liver fibrosis
Metabolic associated fatty liver disease
Non-alcoholic fatty liver disease
Subtype
Online Access:http://www.sciencedirect.com/science/article/pii/S092966462300284X

Internet

http://www.sciencedirect.com/science/article/pii/S092966462300284X

Similar Items